Discontinuation of nucleot(s)ide analogue therapy in HBeAg-negative chronic hepatitis B: a meta-analysis | Gut

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

Hepatology

Original research

Discontinuation of nucleot(s)ide analogue therapy in HBeAg-negative chronic hepatitis B: a meta-analysis

Online download statistics by month:

Online download statistics by month: September 2021 to March 2024

	Abstract	Full	Pdf
Sep 2021	153	120	100
Oct 2021	902	53	43
Nov 2021	613	42	33
Dec 2021	554	15	18
Jan 2022	423	22	12
Feb 2022	397	22	18
Mar 2022	472	22	14
Apr 2022	549	28	12
May 2022	639	20	10
Jun 2022	505	30	12
Jul 2022	1455	130	78
Aug 2022	607	76	55
Sep 2022	396	53	31
Oct 2022	326	44	25
Nov 2022	265	34	15
Dec 2022	188	22	11
Jan 2023	196	21	11
Feb 2023	261	6	6
Mar 2023	157	22	15
Apr 2023	126	13	9
May 2023	252	14	12
Jun 2023	95	13	7
Jul 2023	149	12	8
Aug 2023	157	17	7
Sep 2023	121	14	6
Oct 2023	129	13	5
Nov 2023	166	20	6
Dec 2023	161	6	7
Jan 2024	140	11	8
Feb 2024	127	9	8
Mar 2024	87	8	6
Total	10768	932	608